跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,221 条关于
“secondary hypertension”
全部
19,221
临床试验
13,961
药物
168
机构
17
资讯
5,075
去年
Amlodipine and Candesartan Combination Therapy Shows Superior Efficacy in Treating Hypertension
去年
Childhood Cancer Survivors Face Five-Fold Higher Risk of Kidney Disease and Hypertension
11个月前
Pentixapharm's CXCR4-Targeted Radiopharmaceuticals Show Promise in Primary Aldosteronism and Bladder Cancer
4个月前
Pentixapharm Submits IND to FDA for Phase 3 PANDA Trial of First-in-Class CXCR4-Targeted Cardiovascular Diagnostic
去年
NCI and NIDDK Initiate Phase II Trial of PentixaFor for Adrenal Tumor Subtyping
去年
Pentixapharm's Ga68-PentixaFor Receives EMA PRIME Status for Primary Aldosteronism Diagnosis
去年
Debate Over CAR-T Therapy's Secondary Malignancy Risks Continues
去年
Alzheimer's Prevention Trials Update: Lecanemab, Donanemab, and Remternetug
9个月前
Pentixapharm Receives FDA Guidance for Phase 3 PANDA Study of 68Ga-PentixaFor in Primary Aldosteronism
去年
Advances in Transplant Eligibility Expand Treatment Options for Secondary AML Patients
第 1 页,共 508 页
上一页
下一页